The updated labeling for ReShape Lifesciences' ReShape and Apollo Endosurgery's Orbera liquid-filled intragastric balloon systems has been approved by the FDA. The new labeling will include data on the global occurrence rates tied to adverse events associated with these weight-loss devices, such as acute pancreatitis, spontaneous hyperinflation and death.
ReShape Lifesciences has secured a method and device patent from the US Patent and Trademark Office expanding its neuromodulation intellectual property portfolio. The patent covers a combination of stimulating and blocking the vagus and celiac nerve branches using certain bioelectronic parameters to treat gastrointestinal disorders, obesity and diabetes.
Following rigorous dietary restrictions, losing weight, exercising and undergoing bariatric surgery are some of the ways individuals with type 2 diabetes can reverse the condition or at least go into remission, says George King, research director and chief scientific officer at Boston's Joslin Diabetes Center, although he adds that symptoms can come back over time, particularly if a strict regimen is not followed. Bariatric surgery provides the strongest support, he said, adding, "Of people who undergo bariatric surgery and who have been on diabetes medications for years, fully 50 to 60 percent of these people can go off all medications in five years."
Research presented at the American Society for Nutrition's annual meeting found workers add an average of 1,300 calories to their diet each week by eating foods obtained at work, with more than 70% of those calories coming from free food. Nutritionist Samantha Heller said employers could benefit by offering healthy foods at work to help employees feel better and have more energy.
Obesity rates in the US consistently rose across groups and regions since 1999, with obesity and severe obesity prevalence among boys, but not girls, continuously rising to reach 20.6% and 7.5%, respectively, in 2015-2016, researchers reported at the American Society for Nutrition annual meeting. The findings also showed that nearly 33% of children ages 6 to 11 and about 50% of teens ages 12 to 19 will be overweight or obese by 2030 if current trends continue.
The obesity epidemic and an increase in hepatitis infections have fueled an increase in liver cancer in the US and three other developed countries over the past 25 years, researchers reported at the Global Hepatitis Summit. The UK has the highest incidence of liver cancer at 9.6 per 100,000 people, followed by the US at 9.2 per 100,000, Australia at 7.4 per 100,000 and Canada at 6.0 per 100,000, with similar rankings found for liver cancer mortality.
If 20% more Americans stuck to a healthy diet, the nation would save more than $20 billion in direct and indirect costs associated with heart disease, cancer, type 2 diabetes, stroke, hip fracture, Alzheimer's disease and other conditions, according to a study presented at the American Society for Nutrition's annual meeting. The study indicates that educating Americans on how to improve their diet quality would be financially worthwhile, said lead author Carolyn Scrafford.
A study in the journal Menopause looked at more than 8,200 women in the 70-to-79 age range and found that those who had the highest level of physical activity had the lowest genetic influence on their body mass index, while genetic influences on BMI were strongest in the women who had the least physical activity. "The message here is that your genetic risk for obesity is not wholly deterministic," said study author Heather Ochs-Balcom, noting that life choices play a large role in a person's overall health.
ASGE and ABE are official endorsers of the 2018 James W. Freston Conference on Obesity and Metabolic Disease on Aug. 18-19 in Arlington, Va. The purpose of the event is to provide participants with a framework for discussion of new concepts in obesity pathophysiology, as well as new paradigms in obesity therapies. Get more information.
The American Medical Association's first policy addressing the use of augmented intelligence in health care urges federal policymakers and health care stakeholders to focus on "user-centered design," and the policy calls for the AMA to set priorities for AI tools to improve physician satisfaction and patient outcomes. "Combining AI methods and systems with an irreplaceable human clinician can advance the delivery of care in a way that outperforms what either can do alone," said AMA board member Dr. Jesse Ehrenfeld.
HHS Secretary Alex Azar said the refusal of the Department of Justice and Attorney General Jeff Sessions to defend the Affordable Care Act's provisions offering protections for people with pre-existing conditions against a lawsuit filed by 20 Republican-led states "is a constitutional and legal position, not a policy position." The Trump administration "share[s] the view of working to ensure individuals with pre-existing conditions can have access to affordable health insurance," Azar told lawmakers during a Senate hearing.